Allmed Solutions (XTAE:ALMD) Notes Receivable: ₪0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ALMD Allmed Solutions Ltd XTAE:ALMD
30 GF Score
Price ₪0.32
! 3 Warning Signs
View Full Analysis

What is Allmed Solutions Notes Receivable?

Allmed Solutions XTAE:ALMD 30 Notes Receivable is ₪0.00 Mil as of Dec. 2025. GuruFocus rates XTAE:ALMD with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Allmed Solutions's Notes Receivable for the quarter that ended in Dec. 2025 was ₪0.00 Mil.

Allmed Solutions Notes Receivable Related Terms

Allmed Solutions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Allmed Solutions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allmed Solutions Notes Receivable Chart

Allmed Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Allmed Solutions Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTAE:ALMD
30GF Score
Allmed Solutions Ltd XTAE:ALMD
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allmed Solutions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₪0.00 Mil mean?
Allmed Solutions (XTAE:ALMD) has a Notes Receivable of ₪0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Allmed Solutions and its competitors.
Is Allmed Solutions' Notes Receivable too high?
Allmed Solutions' current Notes Receivable is ₪0.00 Mil. Overall, Allmed Solutions has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Allmed Solutions' Notes Receivable compare to ABT and SYK?
Allmed Solutions' Notes Receivable of ₪0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Allmed Solutions and its competitors. Allmed Solutions's current Notes Receivable is ₪0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allmed Solutions stock overvalued right now?
Allmed Solutions (XTAE:ALMD) has a current Notes Receivable of ₪0.00 Mil. The current Notes Receivable is ₪0.00 Mil. Allmed Solutions' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Allmed Solutions (XTAE:ALMD), the current Notes Receivable is ₪0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Allmed Solutions Business Description

Address 2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501
Allmed Solutions Ltd develops, manufactures and markets minimally invasive products internationally in various medical disciplines.
30GF Score

Get the complete analysis for XTAE:ALMD

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.32
Price